POMC and pituitary tumor: Finally, in vivo and in vitro studies that explain Wnt signaling and active β-CATENIN participation in aggressive corticotroph tumor progression as well as the response to treatments could provide complementary information to consider Wnt signaling as a possible new therapeutic target for aggressive ACTH producing pituitary tumors.